Photo: Avizorex

Photo: Avizorex

Last modified: 17/12/2014

Avizorex closes finance round worth 2.5 million euros

The biotechnology company's new investors include Inveready.

Biotechnology company Avizorex has secured 2.5 million euros from a financing round, with 800,000 invested by venture capital firm Inveready

The company was one of the participants in the last edition of BioEmprenedorXXI promoted by Barcelona ActivaBiocat and "la Caixa". 

This firm has helped develop an ophthalmic drug to combat dry eye syndrome.

Browse all news

Read the last newsletters

Get informed

Subscribe to the Barcelona Business newsletter if you want to receive information on the current state of the economy in Barcelona.